Buy Now: Cabozantinib, Buy Now Cheaper

Cabozantinib (Cabozantinib) is a targeted therapy drug that belongs to the category of multi-target tyrosine kinase inhibitors. It is designed to treat several types of cancer, including advanced renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma.

Given that cabozantinib has not yet obtained marketing approval in China, domestic patients cannot purchase this drug directly from the local market. However, there are opportunities to obtain cabozantinib through foreign channels, which includes original drugs and generic drugs. Original drugsare often expensive. For example, Original drugs from Japan and Europe may be priced as high as 30,000 to 40,000 yuan. Relatively speaking, the price of generic drugs is more affordable. For example, the price range of generic drugs from Laos, India, Bangladesh and other places is only between a few hundred to a few thousand yuan. It is worth noting that whether it is an original drug or a generic drug, the core ingredients of the drug are highly consistent. Therefore, patients can choose the drug that best suits them based on their economic status and disease needs.

As a targeted therapy drug, cabozantinib’s mechanism of action is mainly by inhibiting multiple key signaling pathways, thereby inhibiting the growth, spread and angiogenesis of cancer cells. Cabozantinib mainly acts on multiple receptor tyrosine kinases (RTKs), including MET (hepatocyte growth factor receptor), VEGFR (vascular endothelial growth factor receptor) , RET (rearranged oncogene family receptor kinase), KIT (cytoplasmic tyrosine kinase) and AXL (axon-associated protein kinase), etc. By inhibiting the activity of these receptor tyrosine kinases, cabozantinib can effectively block the growth signaling of tumor cells, thereby inhibiting the growth and metastasis of tumor cells.

In addition, cabozantinib can also inhibit the vascular endothelial growth factor (VEGF) signaling pathway, thereby inhibiting the formation of new blood vessels in tumors, reducing the blood supply to tumors, and thereby inhibiting tumor growth and metastasis.

In general, cabozantinib is a targeted therapy that inhibits tumor cell growth and angiogenesis through multiple signaling pathways. It has shown good efficacy in treating many types of cancer and provides new treatment options for some patients with advanced cancer. However, patients need to closely follow their doctor's instructions when using cabozantinib and promptly report any adverse reactions to ensure optimal treatment effects.